Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Lung Transplants From Hepatitis C-Positive Donors (HCV)
Condition: Lung Diseases Intervention: Drug: Zepatier Sponsors: University of Pennsylvania; Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials